Not applicableEnded earlyNCT02228421What this trial is testingStudy to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Metastatic PeriPharm 29
Testing effectiveness (Phase 2)Ended earlyNCT03666728What this trial is testingSHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLCWho this might be right forLung Neoplasms Jiangsu HengRui Medicine Co., Ltd. 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06951399What this trial is testingTracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung CancerWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IV Without EGFR/ALK MutationNSCLC Adenocarcinoma Rabin Medical Center 30
Not applicableStudy completedNCT03546894What this trial is testingDetermine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC) Treated With Anaplastic Lymphoma Kinase (ALK) InhibitorsWho this might be right forAnaplastic Lymphoma Kinase-positiveCarcinoma Non-small-cell Lung Takeda 111
Not applicableStudy completedNCT05167500What this trial is testingEfficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use TreatmentWho this might be right forMetastatic Non Small Cell Lung Cancer Fundación GECP 118
Testing effectiveness (Phase 2)Study completedNCT01685138What this trial is testingLDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 124
Early research (Phase 1)Study completedNCT02299505What this trial is testingPharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 306
Testing effectiveness (Phase 2)Study completedNCT03647488What this trial is testingStudy of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT03808662What this trial is testingRandomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and LungWho this might be right forTNBC - Triple-Negative Breast CancerTriple Negative Breast CancerNSCLC+4 more Memorial Sloan Kettering Cancer Center 107
Testing effectiveness (Phase 2)Study completedNCT03779191What this trial is testingAlectinib in Combination With Bevacizumab in ALK Positive NSCLCWho this might be right forALK Gene Rearrangement PositiveNon-Squamous Non-Small Cell Neoplasm of Lung Instituto Nacional de Cancerologia de Mexico 41
Large-scale testing (Phase 3)Active Not RecruitingNCT06082635What this trial is testingTGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer Shenzhen TargetRx Co., Ltd. 321
Early research (Phase 1)Active Not RecruitingNCT02321501What this trial is testingCeritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerWho this might be right forALK PositiveLocally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm+3 more M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT02959619What this trial is testingEnsartinib in Non-small Cell Lung Cancer Patients With Positive ALKWho this might be right forSolid TumorNon-Small Cell Lung Cancer Metastatic Betta Pharmaceuticals Co., Ltd. 48
Not applicableUnknownNCT04317651What this trial is testingCrizotinib in ALK Rearranged Non-small-cell Lung CancerWho this might be right forNon Small Cell Lung CancerAdvanced CancerMetastatic Cancer Fondazione Ricerca Traslazionale 500
Large-scale testing (Phase 3)Study completedNCT01828112What this trial is testingLDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and CrizotinibWho this might be right forNon-Small Cell Lung Cancer Novartis Pharmaceuticals 231
Testing effectiveness (Phase 2)Study completedNCT02314364What this trial is testingA Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLCWho this might be right forNon-small Cell Lung Cancer MetastaticTargetable Oncogenes (EGFR, ALK, ROS1) Massachusetts General Hospital 27
Early research (Phase 1)Looking for participantsNCT07140016What this trial is testingGilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC)Anaplastic Lymphoma Kinase (ALK) Positive Astellas Pharma Global Development, Inc. 40
Not applicableUnknownNCT02041468What this trial is testingStudy to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Metastatic Jewish General Hospital 29
Not applicableActive Not RecruitingNCT05721950What this trial is testingLearn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung Cancer (NSCLC) Takeda 154
Not applicableUnknownNCT06410040What this trial is testingA Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal MetastasisWho this might be right forALK-positive Non-small Cell Lung CancerBrain MetastasesMeningeal Metastasis Sichuan Cancer Hospital and Research Institute 28